Investment Rating - The investment rating for the company is "Buy" and is maintained [7]. Core Viewpoints - The company's total revenue for H1 2025 is 1.473 billion yuan, a year-on-year decrease of 11.46%. The net profit attributable to the parent company is 105 million yuan, down 47.2% [2][5]. - In Q2 2025, total revenue is 909 million yuan, a decrease of 6.16%, with a net profit of approximately 89.36 million yuan, down 37.99% [2][5]. - The company is focusing on improving its overseas supply chain layout, particularly in the North American market and through the establishment of a processing base in Nepal [10]. Financial Performance - The company's gross profit margin decreased by 2.55 percentage points to 22.24% in H1 2025, while the net profit margin fell by 4.81 percentage points to 7.1% [10]. - The company expects net profits for 2025, 2026, and 2027 to be 212 million, 266 million, and 321 million yuan respectively, with corresponding EPS of 0.51, 0.64, and 0.78 yuan [10]. Revenue Breakdown - In Q2 2025, revenue from various product categories showed mixed results: "夫妻肺片" down 15.90%, "整禽类" down 19.59%, "香辣休闲类" up 9.84%, "其他鲜货" down 24.40%, and "预包装产品" up 87.84% [10]. - Revenue from different channels in Q2 2025: distribution down 12.03%, direct sales up 71.98%, and other channels up 22.48% [10]. - The overseas revenue for the first half of 2025 reached 6.4873 million yuan, a significant increase of 403.29% [10]. Market Strategy - The company has successfully penetrated the North American market by partnering with Chinese supermarkets and opening direct stores in New York [10]. - A new high-tech slaughterhouse and water buffalo breeding center is being established in Nepal, which is expected to significantly reduce beef import costs [10].
紫燕食品(603057):2025年半报点评:主业环比好转,关注海外供应链布局